Phylogenetic and phenotypic characterization of Burkholderia pseudomallei isolates from Ghana reveals a novel sequence type and common phenotypes

• Published in: Frontiers in microbiology Vol. 15; p. 1401259
• Main Authors: Schully, Kevin L, Voegtly, Logan J, Rice, Gregory K, Drumm, Hannah, Fitzpatrick, Maren C, Malagon, Francisco, Shea, April, Dong, Ming, Oduro, George, Robberts, F J Lourens, Dartey, Paul K A, Owusu-Ofori, Alex, Clark, Danielle V, Cer, Regina Z, Bishop-Lilly, Kimberly A
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 09.07.2024
• Subjects: Africa; Burkholderia pseudomallei; environment; Ghana; melioidosis; Microbiology; phylogenetic; genome; sequence; environment; phylogenetic; Africa; Burkholderia pseudomallei; Ghana; melioidosis
• ISSN: 1664-302X; 1664-302X
• DOI: 10.3389/fmicb.2024.1401259

Melioidosis is a potentially severe disease caused by the gram-negative soil-dwelling bacterium called . The true breadth of the distribution of this tropical pathogen is starting to emerge with environmental and clinical isolates frequently characterized in new countries and regions. Even so, isolates, clinical cases, and genetic data from the continent of Africa remain scant. We previously confirmed the presence of in the environment of Ghana, unmasking a new area of endemicity for this pathogen. Here, we describe the genetic characteristics of isolates obtained from that environmental survey. Twenty-one isolates were subjected to whole genome sequencing and found to represent three discrete sequence types (ST), one of which was novel, and designated ST2058. Phylogenetic analysis places this novel isolate within a clade that includes genomes derived from the Americas, although it is closely related to a sub-clade that includes isolates from Africa. Importantly, phenotypic characterization demonstrates common features including API 20NE profiles and CPS to support existing diagnostics, and susceptibility to standard of care antibiotics often used in the clinical management of melioidosis. These findings add to our knowledge about the presence and distribution of in Africa and represent the first published genomes out of Ghana.